Lysogene S.A.

Symbol: LYS.PA




Market price today

  • -0.3450

    P/E Ratio

  • -0.0081

    PEG Ratio

  • 4.95M

    MRK Cap

  • 0.00%

    DIV Yield

Lysogene S.A. (LYS-PA) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Ms. Karen Pignet-Aiach MBA
Full-time employees:22
Address:18-20 rue Jacques Dulud

Lysogene S.A., a biopharmaceutical gene therapy company, focuses on the discovery and development of therapies for children with neurodegenerative lysosomal storage disorders. Its clinical programs include LYS-SAF302, which is in Phase II/III clinical trial for the treatment of mucopolysaccharidosis type IIIA; and LYS-GM101 that is in Phase I/II trial for the treatment of GM1 gangliosidosis. The company has a collaborative research collaboration with the Weizmann Institute of Science for developing a novel AAV gene therapy approach for neuronopathic gaucher disease, parkinson disease, and other diseases. Lysogene S.A. was incorporated in 2009 and is based in Neuilly-sur-Seine, France.

General Outlook

In simple terms, Lysogene S.A. has 17.696 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.494% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -3.562%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -3.664%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.691% return, is a testament to Lysogene S.A.'s adeptness in optimizing resource deployment. Lysogene S.A.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -11.298%. Furthermore, the proficiency of Lysogene S.A. in capital utilization is underscored by a remarkable -2.522% return on capital employed.

Stock Prices

Lysogene S.A.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.2795, while its low point bottomed out at $0.2795. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Lysogene S.A.'s stock market.

Liquidity Ratios

Analyzing LYS.PA liquidity ratios reveals its financial health of the firm. The current ratio of 120.69% gauges short-term asset coverage for liabilities. The quick ratio (85.02%) assesses immediate liquidity, while the cash ratio (85.02%) indicates cash reserves.

Current Ratio120.69%
Quick Ratio85.02%
Cash Ratio85.02%

Profitability Ratios

LYS.PA profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -364.75% underscores its earnings before tax deductions. The effective tax rate stands at -0.46%, revealing its tax efficiency. The net income per EBT, 100.46%, and the EBT per EBIT, 102.39%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -356.23%, we grasp its operational profitability.

Pretax Profit Margin-364.75%
Effective Tax Rate-0.46%
Net Income per EBT100.46%
EBT per EBIT102.39%
EBIT per Revenue-356.23%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.21, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

Days of Sales Outstanding85
Days of Payables Outstanding278
Cash Conversion Cycle-278
Payables Turnover1.31
Fixed Asset Turnover2.70
Asset Turnover0.19

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.86, and free cash flow per share, -0.87, depict cash generation on a per-share basis. The cash per share value, 0.73, showcases liquidity position. Lastly, the operating cash flow sales ratio, -3.87, offers insight into cash flow relative to sales.

Operating Cash Flow per Share-0.86
Free Cash Flow per Share-0.87
Cash per Share0.73
Operating Cash Flow Sales Ratio-3.87
Free Cash Flow to Operating Cash Flow Ratio1.02
Cash Flow Coverage Ratio-1.46
Short Term Coverage Ratio-40.80
Capital Expenditure Coverage Ratio-50.50
Dividend Paid and Capex Coverage Ratio-50.50

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 50.06%, highlights its total liabilities relative to assets. With a debt-equity ratio of -2.26, we discern the balance between debt and equity financing. The long-term debt to capitalization, 184.68%, and total debt to capitalization, 179.25%, ratios shed light on its capital structure. An interest coverage of -214.37 indicates its ability to manage interest expenses.

Debt Ratio50.06%
Debt Equity Ratio-2.26
Long Term Debt to Capitalization184.68%
Total Debt to Capitalization179.25%
Interest Coverage-214.37
Cash Flow to Debt Ratio-1.46
Company Equity Multiplier-4.52

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.22, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.81, reflects the portion of profit attributed to each share. The book value per share, -0.26, represents the net asset value distributed per share, while the tangible book value per share, -0.28, excludes intangible assets.

Revenue Per Share0.22
Net Income Per Share-0.81
Book Value Per Share-0.26
Tangible Book Value Per Share-0.28
Shareholders Equity Per Share-0.26
Interest Debt Per Share0.59
Capex Per Share-0.02

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 29,828,738.104, captures the company's total value, considering both debt and equity. Income quality, 1.06, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.12, gauges operational efficiency, while the research and development to revenue, 419.75%, highlights investment in innovation. The ratio of intangibles to total assets, 1.38%, indicates the value of non-physical assets, and capex to operating cash flow, 1.98%, measures reinvestment capability.

Enterprise Value29,828,738.104
Income Quality1.06
Sales General and Administrative to Revenue0.12
Research and Development to Revenue419.75%
Intangibles to Total Assets1.38%
Capex to Operating Cash Flow1.98%
Capex to Revenue-7.67%
Capex to Depreciation-78.57%
Stock-Based Compensation to Revenue50.95%
Graham Number2.17
Return on Tangible Assets-70.08%
Graham Net Net-0.70
Working Capital3,002,000
Tangible Asset Value-4,650,000
Net Current Asset Value-6,645,000
Invested Capital-2
Average Payables2,638,000
Days Payables Outstanding278

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -1.08, and the price to book ratio, -1.08, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.33, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -0.34, and price to operating cash flows, -0.33, gauge market valuation against cash flow metrics.

Price Book Value Ratio-1.08
Price to Book Ratio-1.08
Price to Sales Ratio1.33
Price Cash Flow Ratio-0.33
Price Earnings to Growth Ratio-0.01
Enterprise Value Multiple-0.56
Price Fair Value-1.08
Price to Operating Cash Flow Ratio-0.33
Price to Free Cash Flows Ratio-0.34
Price to Tangible Book Ratio-7.37
Enterprise Value to Sales7.99
Enterprise Value Over EBITDA-2.26
EV to Operating Cash Flow-2.07
Earnings Yield-42.37%
Free Cash Flow Yield-45.65%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Lysogene S.A. (LYS.PA) on the EURONEXT in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.345 in 2024.

What is the ticker symbol of Lysogene S.A. stock?

The ticker symbol of Lysogene S.A. stock is LYS.PA.

What is company IPO date?

IPO date of Lysogene S.A. is 2017-02-08.

What is company current share price?

Current share price is 0.280 EUR.

What is stock market cap today?

The market cap of stock today is 4946116.000.

What is PEG ratio in 2024?

The current -0.008 is -0.008 in 2024.

What is the number of employees in 2024?

In 2024 the company has 22.